Aging without apolipoprotein d: Molecular and cellular modifications in the hippocampus and cortex

Experimental Gerontology

Volumn 67, Issue , 2015, Pages 19-47

  Sanchez, Diego ^a   Bajo Grañeras, Raquel ^a   Del Caño Espinel, Manuela ^a   Garcia Centeno, Rosa ^a   Garcia Mateo, Nadia ^a   Pascua Maestro, Raquel ^a   Ganfornina, Maria D ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cognitive decline; Immune response; Lipocalin; Neurodegeneration; Oxidative stress; Reactive gliosis

Indexed keywords

APOLIPOPROTEIN D; TRANSCRIPTOME;

AGING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE EXPRESSION; GLIA CELL; HIPPOCAMPUS; HOMEOSTASIS; HYPERKINESIA; INFLAMMATION; KNOCKOUT MOUSE; LIFESPAN; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; SENESCENCE; ANIMAL; ANIMAL BEHAVIOR; COGNITIVE DEFECT; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PREMATURE AGING;

ANIMALIA;

AGING; AGING, PREMATURE; ANIMALS; APOLIPOPROTEINS D; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; COGNITION DISORDERS; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; TRANSCRIPTOME;

EID: 84928729411     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.04.003     Document Type: Article

References (70)

1. Abou-Sleiman P.M., Muqit M.M., Wood N.W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 2006, 7:207-219.
2. Aljada A., Saleh A.M., Al Suwaidan S. Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug- induced chemoreistance. Diagn. Pathol. 2014, 9:94.
3. Al-Shahrour F., Minguez P., Tarraga J., Montaner D., Alloza E., Vaquerizas J.M., Conde L., Blaschke C., Vera J., Dopazo J. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res. 2006, 34:W472-W476.
4. Alvarez-Lopez M.J., Castro-Freire M., Cosin-Tomas M., Sanchez-Roige S., Lalanza J.F., Del Valle J., Parrizas M., Camins A., Pallas M., Escorihuela R.M., Kaliman P. Long-term exercise modulates hippocampal gene expression in senescent female mice. J. Alzheimers Dis. 2013, 33:1177-1190.
5. Antunes M., Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn. Process. 2012, 13:93-110.
6. Bajo-Graneras R., Ganfornina M.D., Martin-Tejedor E., Sanchez D. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia 2011, 59:1551-1566.
7. Bajo-Graneras R., Sanchez D., Gutierrez G., Gonzalez C., Do Carmo S., Rassart E., Ganfornina M.D. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J. Neurochem. 2011, 117:949-960.
8. Bechade C., Colasse S., Diana M.A., Rouault M., Bessis A. NOS2 expression is restricted to neurons in the healthy brain but is triggered in microglia upon inflammation. Glia 2014, 62:956-963.
9. Bhatia S., Knoch B., Wong J., Kim W.S., Else P.L., Oakley A.J., Garner B. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease. Biochem. J. 2011, 442:713-721.
10. Bhatia S., Jenner A.M., Li H., Ruberu K., Spiro A.S., Shepherd C.E., Kril J.J., Kain N., Don A., Garner B. Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels. J. Alzheimers Dis. 2013, 35:475-486.
11. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
12. Blazejczyk M., Miron M., Nadon R. FlexArray: A statistical data analysis software for gene expression microarrays 2007, Genome Quebec, Montreal.
13. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., Thompson W.J., Barres B.A. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008, 28:264-278.
14. Chen C.P., Chen R.L., Preston J.E. Age-related increase of prostaglandin D(2) synthase concentration and glycation in ovine cerebrospinal fluid. Exp. Gerontol. 2009, 44:639-645.
15. Dassati S., Waldner A., Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol. Aging 2014, 35:1632-1642.
16. de Magalhaes J.P., Curado J., Church G.M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009, 25:875-881.
17. Del Caño-Espinel M., Acebes J.R., Sanchez D., Ganfornina M.D. Lazarillo-related Lipocalins confer long-term protection against type I Spinocerebellar Ataxia degeneration contributing to optimize selective autophagy. Mol. Neurodegener. 2015, 10:11.
18. Do Carmo S., Fournier D., Mounier C., Rassart E. Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E802-E811.
19. Faizi M., Bader P.L., Saw N., Nguyen T.V., Beraki S., Wyss-Coray T., Longo F.M., Shamloo M. Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav. 2012, 2:142-154.
20. Finch C.E. Middle age: an evolving frontier in gerontology. Neurobiol. Aging 1991, 12:1-2.
21. Flynn J.M., Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic. Biol. Med. 2013, 62:4-12.
22. Ganfornina M.D., Do Carmo S., Lora J.M., Torres-Schumann S., Vogel M., Allhorn M., Gonzalez C., Bastiani M.J., Rassart E., Sanchez D. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 2008, 7:506-515.
23. Ganfornina M.D., Do Carmo S., Martinez E., Tolivia J., Navarro A., Rassart E., Sanchez D. ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 2010, 58:1320-1334.
24. Garcia-Mateo N., Ganfornina M.D., Montero O., Gijon M.A., Murphy R.C., Sanchez D. Schwann cell-derived Apolipoprotein D controls the dynamics of post-injury myelin recognition and degradation. Front. Cell. Neurosci. 2014, 8:374.
25. Giblin W., Skinner M.E., Lombard D.B. Sirtuins: guardians of mammalian healthspan. Trends Genet. 2014, 30:271-286.
26. Glorioso C., Sibille E. Between destiny and disease: genetics and molecular pathways of human central nervous system aging. Prog. Neurobiol. 2011, 93:165-181.
27. Goss J.R., Finch C.E., Morgan D.G. Agrelated changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol. Aging 1991, 12:165-170.
28. Goyal V.K. Lipofuscin pigment accumulation in the central nervous system of the mouse during aging. Exp. Gerontol. 1982, 17:89-94.
29. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
30. Hull-Thompson J., Muffat J., Sanchez D., Walker D.W., Benzer S., Ganfornina M.D., Jasper H. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet. 2009, 5:e1000460.
31. Jeong S.M., Xiao C., Finley L.W., Lahusen T., Souza A.L., Pierce K., Li Y.H., Wang X., Laurent G., German N.J., Xu X., Li C., Wang R.H., Lee J., Csibi A., Cerione R., Blenis J., Clish C.B., Kimmelman A., Deng C.X., Haigis M.C. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 2013, 23:450-463.
32. Jimenez-Palomares M., Cozar-Castellano I., Ganfornina M.D., Sanchez D., Perdomo G. Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia. Metabolism 2011, 60:1767-1774.
33. Jung T., Bader N., Grune T. Lipofuscin: formation, distribution, and metabolic consequences. Ann. N. Y. Acad. Sci. 2007, 1119:97-111.
34. Kim W.S., Wong J., Weickert C.S., Webster M.J., Bahn S., Garner B. Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. J. Neurochem. 2009, 109:1053-1066.
35. Kirkwood T.B. Global aging and the brain. Nutr. Rev. 2010, 68(Suppl. 2):S65-S69.
36. Koga H., Kaushik S., Cuervo A.M. Protein homeostasis and aging: the importance of exquisite quality control. Ageing Res. Rev. 2011, 10:205-215.
37. Kosacka J., Schroder T., Bechmann I., Kloting N., Nowicki M., Mittag A., Gericke M., Spanel-Borowski K., Bluher M. PACAP up-regulates the expression of apolipoprotein D in 3T3-L1 adipocytes. DRG/3T3-L1 co-cultures study. Neurosci. Res. 2010, 69:8-16.
38. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 2000, 25:294-297.
39. Leung W.C., Lawrie A., Demaries S., Massaeli H., Burry A., Yablonsky S., Sarjeant J.M., Fera E., Rassart E., Pickering J.G., Rabinovitch M. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ. Res. 2004, 95:179-186.
40. Li H., Ruberu K., Munoz S.S., Jenner A.M., Spiro A., Zhao H., Rassart E., Sanchez D., Ganfornina M.D., Karl T., Garner B. Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice. Neurobiol. Aging 2015, 10.1016/j.neurobiolaging.2015.02.010.
41. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
42. Loerch P.M., Lu T., Dakin K.A., Vann J.M., Isaacs A., Geula C., Wang J., Pan Y., Gabuzda D.H., Li C., Prolla T.A., Yankner B.A. Evolution of the aging brain transcriptome and synaptic regulation. PLoS One 2008, 3:e3329.
43. Lopez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217.
44. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
45. Matsui N., Takahashi K., Takeichi M., Kuroshita T., Noguchi K., Yamazaki K., Tagashira H., Tsutsui K., Okada H., Kido Y., Yasui Y., Fukuishi N., Fukuyama Y., Akagi M. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res. 2009, 1305:108-117.
46. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998, 18:159-163.
47. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
48. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science 1997, 278:412-419.
49. Patel S.C., Asotra K., Patel Y.C., McConathy W.J., Patel R.C., Suresh S. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 1995, 6:653-657.
50. Perdomo G., Kim D.H., Zhang T., Qu S., Thomas E.A., Toledo F.G., Slusher S., Fan Y., Kelley D.E., Dong H.H. A role of apolipoprotein D in triglyceride metabolism. J. Lipid Res. 2010, 51:1298-1311.
51. Rassart E., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L., Milne R. Apolipoprotein D. Biochim. Biophys. Acta 2000, 1482:185-198.
52. Ruiz M., Sanchez D., Canal I., Acebes A., Ganfornina M.D. Sex-dependent modulation of longevity by two Drosophila homologues of human Apolipoprotein D, GLaz and NLaz. Exp. Gerontol. 2011, 46:579-589.
53. Ruiz M., Wicker-Thomas C., Sanchez D., Ganfornina M.D. Grasshopper Lazarillo, a GPI-anchored Lipocalin, increases Drosophila longevity and stress resistance, and functionally replaces its secreted homolog NLaz. Insect Biochem. Mol. Biol. 2012, 42:776-789.
54. Ruiz M., Sanchez D., Correnti C., Strong R.K., Ganfornina M.D. Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation. FEBS J. 2013, 280:3928-3943.
55. Ruiz M., Ganfornina M.D., Correnti C., Strong R.K., Sanchez D. Ligand binding-dependent functions of the lipocalin NLaz: an in vivo study in Drosophila. FASEB J. 2014, 28:1555-1567.
56. Salminen A., Kaarniranta K., Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012, 4:166-175.
57. Sanchez D., Lopez-Arias B., Torroja L., Canal I., Wang X., Bastiani M.J., Ganfornina M.D. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr. Biol. 2006, 16:680-686.
58. Taniike M., Mohri I., Eguchi N., Beuckmann C.T., Suzuki K., Urade Y. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J. Neurosci. 2002, 22:4885-4896.
59. Terao A., AptDeshpande A., Dousman L., Morairty S., Eynon B.P., Kilduff T.S., Freund Y.R. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 2002, 132:99-112.
60. Terman A., Brunk U.T. Lipofuscin. Int. J. Biochem. Cell Biol. 2004, 36:1400-1404.
61. Tsukamoto K., Mani D.R., Shi J., Zhang S., Haagensen D.E., Otsuka F., Guan J., Smith J.D., Weng W., Liao R., Kolodgie F.D., Virmani R., Krieger M. Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:17023-17028.
62. Verbitsky M., Yonan A.L., Malleret G., Kandel E.R., Gilliam T.C., Pavlidis P. Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice. Learn. Mem. 2004, 11:253-260.
63. Vogt M., Skerra A. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J. Mol. Recognit. 2001, 14:79-86.
64. Walker D.W., Muffat J., Rundel C., Benzer S. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr. Biol. 2006, 16:674-679.
65. Wang Y., Nartiss Y., Steipe B., McQuibban G.A., Kim P.K. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy 2012, 8:1462-1476.
66. Wright A.L., Zinn R., Hohensinn B., Konen L.M., Beynon S.B., Tan R.P., Clark I.A., Abdipranoto A., Vissel B. Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. PLoS One 2013, 8:e59586.
67. Xu X., Zhan M., Duan W., Prabhu V., Brenneman R., Wood W., Firman J., Li H., Zhang P., Ibe C., Zonderman A.B., Longo D.L., Poosala S., Becker K.G., Mattson M.P. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biol. 2007, 8:R234.
68. Yankner B.A., Lu T., Loerch P. The aging brain. Annu. Rev. Pathol. 2008, 3:41-66.
69. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinforma. 2006, 7:85.
70. Zahn J.M., Poosala S., Owen A.B., Ingram D.K., Lustig A., Carter A., Weeraratna A.T., Taub D.D., Gorospe M., Mazan-Mamczarz K., Lakatta E.G., Boheler K.R., Xu X., Mattson M.P., Falco G., Ko M.S., Schlessinger D., Firman J., Kummerfeld S.K., Wood W.H., Zonderman A.B., Kim S.K., Becker K.G. AGEMAP: a gene expression database for aging in mice. PLoS Genet. 2007, 3:e201.